🇺🇸 FDA
Company

ALTERITY

ALTERITY THERAPEUTICS LTD

ATHE pharma USA

Quick answer

ALTERITY is a pharma company (ATHE) headquartered in MELBOURNE, USA with 2 tracked pipeline programs.

Pipeline (2)

project

ATH434

Multiple System Atrophy

Phase 2 · small_molecule · completed

1 trials project

ATH434 dose level 1

Multiple System Atrophy

Phase 2 · small_molecule · completed

1 trials

Patents (4)

patent

US 11603364

Acyl hydrazone derivative compounds for treating disease

Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11357770

Method of treating immunoglobulin light chain amyloidosis

Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11155547

Compounds for and methods of treating diseases

Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10941143

Imidazo [1,5-a]pyridine compounds and their use

Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)